Cost effectiveness analyses of pharmacological treatments in heart failure

• Váldodahkkit: Audrey Huili Lim (Dahkki), Nusaibah Abdul Rahim (Dahkki), Jinxin Zhao (Dahkki), S. Y. Amy Cheung (Dahkki), Yu-Wei Lin (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

In a rapidly growing and aging population, heart failure (HF) has become recognised as a public health concern that imposes high economic and societal costs worldwide. HF management stems from the use of highly cost-effective angiotensin converting enzyme inhibitors (ACEi) and β-blockers to the use...